Skip to main content
. 2026 Feb 20;28:78. doi: 10.1186/s13075-026-03770-5

Table 3.

Comparison of ASyS clinical manifestations between our cohort and Asian cohorts

Variable Japan China
Our cohort Hamaguchi
et al. [22]
Yamamoto
et al. [5]
Zhang
et al. [17]
Shi
et al. [23]
Number of cases, n 48 165 125 119 124
Female, n (%) 35 (73) 130 (79) 92 (74) 88 (74) 94 (76)

Age at onset (years),

mean (range)

56.5

(27–87)

53

(18–79)

57.5

(45–68)

54

[50–60]

50.4

(mean)

Anti-Jo1 antibody positive, n (%) 17 (35) 59 (36) 34 (27) 59 (50) 62 (50)
ILD, n (%) 47 (98) 155 (94) 125 (100) 111 (93) 117 (94)
Raynaud’s phenomenon, n (%) 6 (13) 40 (24) 17 (23) 18 (15) 12 (10)
Malignancy, n (%) 6 (13) 19 (12) 5 (4) - 8 (7)
Muscle weakness, n (%) 25 (52) 95 (58) 82 (66) 53 (45) 79 (64)
Skin involvement, n (%)
 Gottron’s sign (hand) 23 (48) 63 (38) - - -
 Gottron’s sign (elbow and/or knee) 25 (52) 51 (31) - - -
 Gottron’s sign 35 (73) - 23 (18) - -
 Gottron’s papules 8 (17) - 50 (40) 20 (17) 55 (44)
Heliotrope rash 9 (19) 26 (16) 33 (17) 9 (19) 0.485
Mechanic’s hands 31 (65) 67 (41) 64 (50) 67 (56) 57 (46)
 Shawl sign 10 (21) - - 7 (6) -
 V-neck sign 6 (13) - - 10 (8) -

ILD Interstitial lung disease